Amphastar Pharmaceuticals Inc (AMPH)
38.27
-0.85
(-2.17%)
USD |
NASDAQ |
Dec 24, 16:00
Amphastar Pharmaceuticals Profit Margin (Quarterly): 21.14% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| BridgeBio Pharma Inc | -5.93K% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.56% |
| Return on Assets | 10.28% |
| Return on Invested Capital | 12.41% |
| Gross Profit Margin (Quarterly) | 53.31% |
| Operating Margin (Quarterly) | 29.83% |
| Return on Net Operating Assets | 13.44% |